Found 486 articles
Synthekine Appoints Geoff Nosrati, Ph.D., as Chief Business Officer and Announces Executive Leadership Changes
Synthekine Inc., an engineered cytokine therapeutics company, announced the appointment of Geoff Nosrati, Ph.D., as chief business officer.
Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials
Medable Inc., the leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials.
Unlocking Product Validation: Bioz and CE Elantech Set a New Standard for Success in Scientific Research
Bioz, Inc., a leading Silicon Valley based AI software company committed to empowering scientists towards optimal scientific discovery, is delighted to announce its partnership with CE Elantech.
The handful of biotechs that went public in 2023 fared well, providing hope to a cautiously optimistic sector.
Bioz, Inc., a leading Silicon Valley-based AI software company committed to advancing scientific discovery, is excited to announce its partnership with Innovative Research. Innovative Research is a leading supplier of lab reagents, including plasma, serum, tissues, and proteins.
Lynx.MD, a leading medical data intelligence platform, announced a new partnership with Allied Digestive Health (ADH), a company of Assured Healthcare Partners (AHP).
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
WRQ Sciences and Superfluid Dx, Inc., announced the completion of an oversubscribed Series A financing led by WRQ Sciences.
VIVALDI BIOSCIENCES RECEIVES GRANT TO STUDY ITS UNIVERSAL FLU VACCINE’S ABILITY TO BLOCK VIRUS TRANSMISSION
Vivaldi Biosciences today announced it has received a grant from Flu Lab to evaluate the potential of its DeltaFLU universal influenza vaccine, administered by nasal spray, to block influenza virus transmission and spread of infection and disease.
Evommune, Inc. and Accutar Biotechnology Inc. today announced a new strategic partnership focused on the discovery of novel small molecule drug candidates in chronic inflammatory diseases.
In this deep dive, BioSpace examines how small, medium and large companies are using artificial intelligence and machine learning to enhance their drug discovery efforts.
Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session
Endologix LLC announced results from a pooled analysis of DETOUR1 and DETOUR2 Studies evaluating Percutaneous Transmural Arterial Bypass with the DETOUR System.
Alto Neuroscience today announced the appointment of Andrew Dreyfus, former president and CEO of BCBSMA, to the company’s board of directors as an independent board member.
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round.
The call to develop therapeutics that interfere with aging, helping people live longer, healthier lives, is increasing—and experts say the market opportunity is high.
BridgeBio and Resilience Announce Strategic Multi-Year Partnership to Advance BBP-631, BBP-812 and Future Gene Therapy Treatments
BridgeBio Pharma, Inc. and National Resilience, Inc. today announced a strategic collaboration to manufacture and advance BBP-812, an investigational adeno-associated virus (AAV) 9 gene therapy for Canavan disease, and BBP-631, an investigational AAV 5 gene therapy for congenital adrenal hyperplasia (CAH).
Curio Bioscience Launches New Curio Seeker 10x10 Kit to Enable the Simultaneous Capture of Nearly One Million Spatial Transcriptomes
Curio Bioscience today announced an expansion of its Curio Seeker product line with a larger format to deliver a more complete view of large biological structures, including human tissue samples, providing one hundred times more data compared to other whole transcriptome spatial analysis solutions.
Arc Institute, the scientific research organization pioneering new models for scientific discovery and translation, is announcing the selection of its new fully funded Core Investigator and first Science Fellow, along with its first Innovation Investigators and Ignite Award Recipients.
Ganymede Bio and Kytopen Partner to Bring Cloud-Native, Structured Data to Gene-Modified Cell Therapy Instruments
Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialization of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen's Flowfect® platforms.
New Post Hoc Analysis Showed Substantial Improvement in Observed Estimated Glomerular Filtration Rate (eGFR), in TransCon PTH-Treated Adults with Hypoparathyroidism
Ascendis Pharma A/S (Nasdaq: ASND) today announced new post hoc analysis showing adults with hypoparathyroidism treated with TransCon PTH demonstrated substantial improvement in estimated glomerular filtration rate (eGFR), suggesting improved kidney function.